Related references
Note: Only part of the references are listed.Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial
Leyi Lin et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States
Aaron Glass et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Functional Interactions of Common Allotypes of Rhesus Macaque FcγR2A and FcγR3A with Human and Macaque IgG Subclasses
Michael W. Grunst et al.
JOURNAL OF IMMUNOLOGY (2020)
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine
Iris Valdes et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines
Maria Beatriz Borges et al.
PLOS PATHOGENS (2019)
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Iris Valdes et al.
FRONTIERS IN IMMUNOLOGY (2019)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine
Gregory D. Gromowski et al.
VACCINE (2018)
WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2018)
WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2018)
Safety concerns derail dengue vaccination program
Dennis Normile
SCIENCE (2017)
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques
Michael K. McCracken et al.
PLOS PATHOGENS (2017)
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Stephen S. Whitehead
EXPERT REVIEW OF VACCINES (2016)
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
Chukiat Sirivichayakul et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
A 12-Month–Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America
Gustavo Olivera-Botello et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway et al.
LANCET INFECTIOUS DISEASES (2016)
Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru A Randomized Trial
Pio Lopez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
Leah C. Katzelnick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
Lalita Priyamvada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
Beth D. Kirkpatrick et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Status of vaccine research and development of vaccines for dengue
Kirsten S. Vannice et al.
VACCINE (2016)
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
Kimia Kardani et al.
VACCINE (2016)
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
Sophia Gailhardou et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Prospects for dengue vaccines for travelers
Sl-Ki Lim et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2016)
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial
Luis Javier Martinez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
Stefan Fernandez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Monitoring and improving the sensitivity of dengue nested RT-PCR used in longitudinal surveillance in Thailand
Chonticha Klungthong et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
Sarah L. George et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D. Kirkpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
Richard Rupp et al.
VACCINE (2015)
Trials and tribulations on the path to developing a dengue vaccine
Stephen J. Thomas et al.
VACCINE (2015)
Development of a recombinant, chimeric tetravalent dengue vaccine candidate
Jorge E. Osorio et al.
VACCINE (2015)
Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial
Veerachai Watanaveeradej et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Clinical and laboratory predictive markers for acute dengue infection
Tzong-Shiann Ho et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants
Veerachai Watanaveeradej et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
Mario Lobigs et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
Monika Simmons et al.
VIROLOGY (2010)
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults
Wellington Sun et al.
HUMAN VACCINES (2009)
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children
Sriluck Simasathien et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2008)
Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization
Annette A. Kraus et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention
Ana P. Goncalvez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Neutralizing antibodies after infection with dengue 1 virus
Maria G. Guzman et al.
EMERGING INFECTIOUS DISEASES (2007)
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein Vaccines in rhesus macaques
Monika Simmons et al.
JOURNAL OF VIROLOGY (2006)
Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever
A Wilder-Smith et al.
CLINICAL INFECTIOUS DISEASES (2004)
Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: Selection of safe and immunogenic monovalent vaccines
N Kanesa-Thasan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
Modification of dengue virus strains by passage in primary dog kidney cells: Preparation of candidate vaccines and immunization of monkeys
KH Eckels et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine
R Edelman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy
AG Pletnev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine
M Simmons et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Immunopathogenesis of dengue virus infection
HY Lei et al.
JOURNAL OF BIOMEDICAL SCIENCE (2001)
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay
AJ Johnson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2000)
Share Paper
